Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100737Source: DataRank Database

Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements is a research paper published in Cell Reports Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.72)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Yonatan N. Degefu ORCID,Nhi Van ORCID,Artem Sokolov ORCID,Bree B. Aldridge ORCID,Jonah Larkins‐Ford ORCID

Live enrichment

PubMed:36084643 PMC:PMC9512659 OpenAlex:https://openalex.org/W4296772075

National Institutes of Health

Grant: 1U54CA225088

Bill and Melinda Gates Foundation

Grant: OPP1189457

NCI NIH HHS

Grant: U54 CA225088

NIAID NIH HHS

Grant: T32 AI007422

National Institutes of Health

Grant: 5U54CA225088-05

Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs

FWCI

5.72

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.cell.com/article/S2666379122002865/pdf

publisherhttp://www.cell.com/article/S2666379122002865/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666379122002865?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666379122002865?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.xcrm.2022.100737

Fields of Study

Computational Drug Discovery MethodsTuberculosis Research and Epidemiologythermodynamics and calorimetric analyses0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntitubercular AgentsDrug CombinationsLinezolidMiceMice, Inbred BALB CTuberculosis

MeSH Terms

LinezolidAnimalsAntitubercular AgentsDrug CombinationsMice, Inbred BALB CTuberculosisMice

Keywords

DrugPairwise comparisonDrug responseTuberculosisMedicineComputer sciencePharmacologyArtificial intelligencePathologyAntibioticsInfectious diseasesMicrobiologyDrug interactionsCombination therapyMachine LearningMultidrug TherapyDrug CombinationsMiceMice, Inbred BALB CAntitubercular AgentsLinezolidAnimalsArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being